Yttrium-90 radioembolization for unresectable neuroendocrine tumor liver metastases / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
;
(12): 355-357, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-496904
ABSTRACT
Neuroendocrine tumor liver metastases (NETLM) is a uncommon advanced tumor disease.Patients with unresectable NETLM have a poor outcome.The management of unresectable NETLM is a clinical dilemma.However,Yttrium-90 radioembolization is a safe and effective treatment for NETLM patients.The median disease control rate is 87.1% (64.7% ~ 100%);the median overall survival time is 34.4 months;and the median overall survival rate of 1,2,and 3 years are 79.8% (63%~100%),62% (57% ~62.5%),45.5% (45% ~ 46%),respectively.Although there is good result of Yttrium-90 radioembolization in treatment of unresectable NETLM,the safety and effectiveness should be further verified.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Hepatobiliary Surgery
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS